The historical rank and industry rank for Krsnaa Diagnostics's FCF Margin % or its related term are showing as below:
NSE:KRSNAA'
s FCF Margin % Range Over the Past 10 Years
Min: -27.36 Med: -11.61 Max: 9.01
Current: -9.86
During the past 8 years, the highest FCF Margin % of Krsnaa Diagnostics was 9.01%. The lowest was -27.36%. And the median was -11.61%.
NSE:KRSNAA's FCF Margin % is ranked worse than 60.59% of 203
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.89
vs NSE:KRSNAA: -9.86
Krsnaa Diagnostics FCF Margin % Related Terms
Krsnaa Diagnostics FCF Margin % Historical Data
* Premium members only.
The historical data trend for Krsnaa Diagnostics's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:KRSNAA vs TMO, DHR, IDXX: FCF Margin % Comparison
For the Diagnostics & Research subindustry, Krsnaa Diagnostics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Krsnaa Diagnostics FCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Krsnaa Diagnostics's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Krsnaa Diagnostics's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krsnaa Diagnostics (NSE:KRSNAA) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Krsnaa Diagnostics and its competitors. According to the industry distribution chart, Krsnaa Diagnostics ranks #123 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 60.6%.
Is Krsnaa Diagnostics' FCF Margin % too high?
Krsnaa Diagnostics' current FCF Margin % is 0.00%. Based on the distribution chart, Krsnaa Diagnostics ranks #123 out of 203 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Krsnaa Diagnostics has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Krsnaa Diagnostics' FCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Krsnaa Diagnostics ranks #123 out of 203 companies for FCF Margin %. This places Krsnaa Diagnostics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Krsnaa Diagnostics and its competitors. Krsnaa Diagnostics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krsnaa Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Krsnaa Diagnostics (NSE:KRSNAA) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹898.08, compared to a current price of ₹538.25 — trading 40.1% below its estimated fair value. The current FCF Margin % is 0.00%. Krsnaa Diagnostics' overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Krsnaa Diagnostics (NSE:KRSNAA), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Krsnaa Diagnostics (NSE:KRSNAA) Overvalued in 2026?
Based on GuruFocus' analysis, Krsnaa Diagnostics stock appears to be undervalued.
The current stock price of ₹538.25 is trading 40.1% below its estimated GF Value™ of ₹898.08.
GuruFocus considers Krsnaa Diagnostics to be Significantly Undervalued.
Key valuation signals for NSE:KRSNAA:
FCF Margin %: 0.00%
GF Value™: ₹898.08 vs. price of ₹538.25 (40.1% below fair value)
No single metric tells the full story. See the NSE:KRSNAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Krsnaa Diagnostics Ltd is a diagnostic services provider, both in Radiology and Pathology. It offers a wide range of diagnostic services such as imaging/radiology services, routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres. The company's operations predominantly relate to providing Radiology and Pathology services for X Ray, CT Scan, MRI, Mammography, tele-reporting services, and all types of Blood and Urine investigations.
71GF Score
Get the complete analysis for NSE:KRSNAA
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KRSNAA has been successfully added to your 
